Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population.
Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population.
复制标题
DOI：
10.1016/s2665-9913(20)30286-1
复制
发表时间：
2020-10
期刊：
影响因子：
--
通讯作者：
Wolbink G
中科院分区：
文献类型：
--
作者：
Hooijberg F;Boekel L;Vogelzang EH;Leeuw M;Boers M;van Vollenhoven R;Lems WF;Nurmohamed MT;Wolbink G
关于弱势患者群体（包括风湿病患者，特别是接受免疫抑制抗风湿药（包括生物制剂）治疗的患者）中COVID-19发病率增加的风险，一直存在争议。到目前为止，关于这些组中COVID-19发病率和结局的结果令人放心：迄今为止，风湿病的存在和免疫抑制药物的使用均未显示与COVID-19的较高感染率或病程恶化有关。1-5然而，这些研究没有考虑到患者采取的预防措施，尽管表明患者意识到他们的感染风险可能会增加。如果患者比一般人群采取更严格的隔离措施，我们可能会错误地放心。在本研究中，我们比较了隔离措施
There is a continuous debate about the risks of increased incidence of COVID-19 in vulnerable patient groups, which includes patients with rheumatic diseases and especially those treated with immunosuppressive antirheumatic drugs, including biologics. So far, results on the incidence and the outcomes of COVID-19 in these groups are reassuring: to date, neither presence of a rheumatic disease nor use of immunosuppressive medication have shown associations with higher infec tion rates or worse disease course of COVID-19. 1–5 However, these studies do not account for preventive measures taken by patients, despite suggestions that patients are aware that their infection risk might be increased. 1, 4, 5 If patients subject themselves to stricter isolation measures than the general population, we might be falsely reassured. In this study, we compared the isolation measures